Showing results (81-90 of 129) with videos related to

Sort By:
Pageof 13
Journal of Clinical Microbiology|August 15, 1998
Prevalence of and factors associated with visceral leishmaniasis in human immunodeficiency virus type 1-infected patients in southern SpainJ A Pineda, J A Gallardo, J Macías, et al.
Journal of Viral Hepatitis|June 24, 2006
Insulin resistance is not associated with liver fibrosis progression in HIV/hepatitis C virus-coinfected patientsN Merchante, J Macías, E Ramayo, et al.
HIV Medicine|January 25, 2017
Fat mass and obesity-associated gene variations are related to fatty liver disease in HIV-infected patientsR Núñez-Torres, J Macías, A Rivero-Juarez, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|October 24, 2003
Impaired recovery of CD4+ cell counts following highly active antiretroviral therapy in drug-naïve patients coinfected with human immunodeficiency virus and hepatitis C virusJ Macías, J A Pineda, F Lozano, et al.
Natural Product Communications|November 30, 2018
Lathyrane Diterpenes from the Latex of Euphorbia laurifoliaMaría Jesús Durán-Peña, María Eugenia Flores-Giubi, José Manuel Botubol-Ares, et al.
The International Journal of Neuropsychopharmacology|July 31, 2015
12-Deoxyphorbols Promote Adult Neurogenesis by Inducing Neural Progenitor Cell Proliferation via PKC ActivationNoelia Geribaldi-Doldán, Eugenia Flores-Giubi, Maribel Murillo-Carretero, et al.
Phytochemistry|October 10, 2020
Bond reactivity indices approach analysis of the [2+2] cycloaddition of jatrophane skeleton diterpenoids from Euphorbia gaditana Coss to tetracyclic gaditanoneM Eugenia Flores-Giubi, Jose Manuel Botubol-Ares, María J Durán-Peña, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|July 17, 2001
Evidence of increased risk for leishmania infantum infection among HIV-seronegative intravenous drug users from southern SpainJ A Pineda, J Macías, F Morillas, et al.
The Pharmacogenomics Journal|June 1, 2016
HLA-B18 as a risk factor of short-term progression to severe liver fibrosis in HIV/HCV co-infected patients with absent or minimal fibrosis: implications for timing of therapyM Frías, D Rodríguez-Cano, F Cuenca-López, et al.
HIV Clinical Trials|October 30, 2003
Relationship between low bone mineral density and highly active antiretroviral therapy including protease inhibitors in HIV-infected patientsJ Fernández-Rivera, R García, F Lozano, et al.
Pageof 13